Krishna Institute of Medical Sciences receives SEBI's nod to launch IPO

04 May 2021 Evaluate

Krishna Institute of Medical Sciences (KIMS) has received capital markets regulator SEBI's go-ahead to float initial share-sales. The company had filed its preliminary papers with the Securities and Exchange Board of India (SEBI) in February. SEBI'S observation is necessary for any company to launch public issues like initial public offer (IPO), follow-on public offer (FPO) and rights issue.

KIMS' initial public offering (IPO) consists of fresh issue of shares aggregating up to Rs 200 crore and an offer for sale of up to 21,340,931 equity shares from promoters and existing shareholders. A total of 1,39,77,991 equity shares would be offered by General Atlantic Singapore KH Pte Ltd under the offer for sale, up to 7,75,933 equity shares by Bhaskara Rao Bollineni, up to 11,63,899 equity shares by Rajyasri Bollineni, up to 3,87,966 equity shares by Bollineni Ramanaiah Memorial Hospitals Pvt Ltd. The offer includes a reservation for subscription by eligible employees. The IPO is likely to fetch Rs 700 crore. The proceeds from the fresh issue will be used to repay debt of the company and its subsidiaries.

KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It operates nine multi-specialty hospitals under the 'KIMS Hospitals' brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of December 31, 2020. KIMS Hospitals offer a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother and child care. The equity shares of the company are proposed to be listed on the BSE and the NSE.

© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.